Use of ERBB4 as a prognostic and therapeutic marker for melanoma

Details for Australian Patent Application No. 2009314534 (hide)

Owner The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Samuels, Yardena R.; Prickett, Todd D.

Agent Fisher Adams Kelly

Pub. Number AU-A-2009314534

PCT Pub. Number WO2010/056406

Priority 61/199,156 12.11.08 US

Filing date 6 August 2009

Wipo publication date 20 May 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056406 Priority application(s): WO2010/056406

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009314536-Vessel compressor methods and systems

2009314512-Lenalidomide solvates and processes